Zhang and Giulietti reported that lncRNA PSMB8-AS1 could contributed to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis and might enable to serve as a prognostic biomarker for pancreatic cancer [42,43]. Here, PSMB8 is linked to familial pancreatic carcinoma.